Real-World Outcomes in Patients with COPD Initiating Budesonide/Glycopyrronium/Formoterol Fumarate Dihydrate After Dual and Triple Therapy in Spain: A Sub-Study of the ORESTES Study.
- DOI
- 10.1007/s41030-026-00341-6
- Published
- 2026 Mar
- Container
- Pulmonary therapy
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s41030-026-00341-6,
title = {Real-World Outcomes in Patients with COPD Initiating Budesonide/Glycopyrronium/Formoterol Fumarate Dihydrate After Dual and Triple Therapy in Spain: A Sub-Study of the ORESTES Study.},
author = {Figueira-Gonçalves JM and Alcázar-Navarrete B and Casitas-Mateo R and González J and Gotera-Rivera CM and Herrejón-Silvestre A and Margallo-Iribarnegaray J and Martín-Lana M and Pallarés-Sanmartín A and Pascual-Guardia S and Saura-Vinuesa A and Corregidor-García C and Fitas E and Sánchez-Covisa J},
year = {2026},
journal = {Pulmonary therapy},
doi = {10.1007/s41030-026-00341-6},
url = {https://doi.org/10.1007/s41030-026-00341-6}
}RIS
TY - JOUR TI - Real-World Outcomes in Patients with COPD Initiating Budesonide/Glycopyrronium/Formoterol Fumarate Dihydrate After Dual and Triple Therapy in Spain: A Sub-Study of the ORESTES Study. AU - Figueira-Gonçalves JM AU - Alcázar-Navarrete B AU - Casitas-Mateo R AU - González J AU - Gotera-Rivera CM AU - Herrejón-Silvestre A AU - Margallo-Iribarnegaray J AU - Martín-Lana M AU - Pallarés-Sanmartín A AU - Pascual-Guardia S AU - Saura-Vinuesa A AU - Corregidor-García C AU - Fitas E AU - Sánchez-Covisa J PY - 2026 JO - Pulmonary therapy DO - 10.1007/s41030-026-00341-6 UR - https://doi.org/10.1007/s41030-026-00341-6 ER -
APA
JM, F., B, A., R, C., J, G., CM, G., A, H., J, M., M, M., A, P., S, P., A, S., C, C., E, F., & J, S. (2026). Real-World Outcomes in Patients with COPD Initiating Budesonide/Glycopyrronium/Formoterol Fumarate Dihydrate After Dual and Triple Therapy in Spain: A Sub-Study of the ORESTES Study.. Pulmonary therapy. https://doi.org/10.1007/s41030-026-00341-6
Source records
- pubmed · retrieved 2026-09-26T14:10:23.293Z